Trevor W. Stone
Glasgow, SCT G128QQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: March 25, 2011
Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
Journal: Handbook of experimental pharmacology
Published: July 30, 2009
Tryptophan, adenosine, neurodegeneration and neuroprotection.
Journal: Metabolic brain disease
Published: August 23, 2007
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.
Journal: The European journal of neuroscience
Published: April 27, 2007
Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist.
Journal: Journal of neuroscience research
Published: February 17, 2007
Adenosine, neurodegeneration and neuroprotection.
Journal: Neurological research
Published: April 15, 2005
Pre-conditioning protection in the brain.
Journal: British journal of pharmacology
Published: September 13, 2003
Tryptophan metabolites and brain disorders.
Journal: Clinical chemistry and laboratory medicine
Published: August 28, 2003
Endogenous kynurenines as targets for drug discovery and development.
Journal: Nature reviews. Drug discovery
Published: October 31, 2002
The pharmacological manipulation of glutamate receptors and neuroprotection.
Journal: European journal of pharmacology
Published: August 02, 2002
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.
Journal: Progress in neurobiology
Published: March 10, 2001
Last Updated: 09/26/2026